|
Video: What is a Stock Split?
|
|
Delcath Systems is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. Co.'s primary product candidate, the HEPZATO KIT (melphalan hydrochloride for injection/hepatic delivery system) (HEPZATO), is a drug/device combination product. HEPZATO is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. In Europe, Co.'s commercial product is a stand-alone medical device having the same device components as the HEZPATO but without the melphalan hydrochloride and is approved for sale under the trade name CHEMOSAT® Hepatic Delivery System for Melphalan. According to our Delcath Systems stock split history records, Delcath Systems has had 2 splits. | |
|
Delcath Systems (DCTH) has 2 splits in our Delcath Systems stock split history database. The first split for DCTH took place on April 09, 2014. This was a 1 for 16 reverse split, meaning for each 16 shares of DCTH owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 62.5 share position following the split. DCTH's second split took place on July 21, 2016. This was a 1 for 16 reverse split, meaning for each 16 shares of DCTH owned pre-split, the shareholder now owned 1 share. For example, a 62.5 share position pre-split, became a 3.90625 share position following the split.
When a company such as Delcath Systems conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the Delcath Systems stock split history from start to finish, an original position size of 1000 shares would have turned into 3.90625 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Delcath Systems shares, starting with a $10,000 purchase of DCTH, presented on a split-history-adjusted basis factoring in the complete Delcath Systems stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
05/03/2018 |
|
End date: |
04/24/2024 |
|
Start price/share: |
$1.35 |
|
End price/share: |
$5.45 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
303.70% |
|
Average Annual Total Return: |
26.28% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$40,370.49 |
|
Years: |
5.98 |
|
|
|
Date |
Ratio |
04/09/2014 | 1 for 16 | 07/21/2016 | 1 for 16 |
|
|